Graduated compression stockings did not prevent deep venous thrombosis after stroke and increased skin complications
- SECTION INDEX. // Monthly Prescribing Reference;Jan2016, Vol. 32 Issue 1, pA20
A section index for the January 1, 2016 issue of the "Monthly Prescribing Reference" journal is presented.
- Does calf DVT really require anticoagulation? Hunt, Beverley // Pulse;5/7/2008, Vol. 68 Issue 16, p43
The article provides an answer to a question concerning venous thromboembolism.
- Low CD34+ cells, high neutrophils and the metabolic syndrome are associated with an increased risk of venous thromboembolism. RATTAZZI, Marcello; VILLALTA, Sabina; GALLIAZZO, Silvia; DEL PUP, Laura; SPONCHIADO, Alessandra; FAGGIN, Elisabetta; BERTACCO, Elisa; BUSO, Roberta; SEGANFREDDO, Elena; PAGLIARA, Valeria; CALLEGARI, Elena; PUATO, Massimo; CABERLOTTO, Livio; SCANNAPIECO, Gianluigi; Paolo FADINI, Gian; PAULETTO, Paolo // Clinical Science;2013, Vol. 125 Issue 4, p211
The relationship between MetS (metabolic syndrome), levels of circulating progenitor/immune cells and the risk of VTE (venous thromboembolism) has not yet been investigated. We studied 240 patients with previous VTE and 240 controls. The presence of MetS was identified according to NCEP ATP III...
- Clinical models and biochemical predictors of VTE in lung cancer. Roselli, M.; Riondino, S.; Mariotti, S.; La Farina, F.; Ferroni, P.; Guadagni, F. // Cancer & Metastasis Reviews;Sep2014, Vol. 33 Issue 2/3, p771
Venous thromboembolism (VTE) is a frequent complication of lung cancer and its treatment, especially in the advanced stages of disease. The risk of a pro-thrombotic state might increase through the activation of hemostasis, occurring both via the induction of a pro-coagulant activity and with...
- Anatomical Study of Chiari Network and the Remnant of Left Venous Valve in the Interior of Right Atrium. Jansirani, D. Devi; Deep, S. Shiva; Anandaraja, S. // Anatomy Research International;9/9/2015, Vol. 2015, p1
Chiari network occurs due to incomplete resorption of right valve of sinus venosus. It is often noticed as fenestrated membranous structure or reticular network like structure in the valve of inferior vena cava and coronary sinus. The remnant of left venous valve is observed as trabeculae over...
- SUBMANDIBULAR AND LATERO - CERVICAL PHLEGMON AS A RESULT OF A PERIAPICAL PATHOLOGY. FAGEŢAN, M. I.; IVAN, IRINA // Acta Medica Transilvanica;dec2012, Vol. 17 Issue 4, p300
The phlegmon is a diffused suppuration with an extensive character, with no suppurated collection. It is characterized by vascular thrombosis, extended necrosis and the presence of gaseous blisters. The siderite tissue is infiltrated with sangvinolent serosity, rarely purulent, very fetid that...
- Can we safely ignore borderline D-dimer? Rugman, Frank // Pulse;1/19/2004, Vol. 64 Issue 3, p70
Presents a question and answer regarding the role of D-dimers to the development of vascular diseases. Prevalence of venous thromboembolism; Sensitivity of the blood plasma, D-dimers and cross-linked fibrin derivatives as a marker for thrombosis; Difficulty of identifying the true cause for the...
- Molecular Diagnostics of Inherited Thrombosis. League, Stacy; Hooper, W. Craig // Clinical Laboratory Science;Fall2005, Vol. 18 Issue 4, p271
Thrombophilia can best be defined as a disorder of coagulation that contributes to a predisposition towards thrombosis. Although the term thrombophilia has been used to describe arterial thrombosis, its most common usage has been in reference to venous thromboembolism (VTE). Thrombophilia can be...
- Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-(mu)g oestrogen preparations. Meade, T.W.; Greenberg, Gillian; Thompson, S.G. // British Medical Journal;5/10/1980, Vol. 280 Issue 6224, p1157
Examines the possibility of cardiovascular reactions from combined estrogen-progestogen oral contraceptives. Association between norethisterone and deaths from stroke and ischemic heart disease; Effort to minimize dose of progestogen; Reduction of thromboembolism.